Responses

PDF

Protocol for a pragmatic cluster randomised controlled trial for reducing irrational antibiotic prescribing among children with upper respiratory infections in rural China
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Clarifications of Manuscript ID bmjopen-2015-010544.R1
    • Xiaolin WEI, Associate Professor
    • Other Contributors:
      • Joseph Hicks, John Walley, Zhitong Zhang, Simin Deng, Jun Zeng, Guanyang Zou, Mei Lin

    Re: http://bmjopen.bmj.com/content/6/5/e010544.ful

    We, on behalf of all authors, would like to clarify a) the definitions of outcome indicators in our trial protocol and analysis plan, which were not consistently defined in all places, and b) our explanation of our ethics situation regarding patient consent:

    1. Page 5 Outcomes:

    The primary outcome of the antibiotic prescription rate (APR) and a...

    Show More
    Conflict of Interest:
    None declared.